N-methyl-d-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels

Schizophrenia Research

Volumn 84, Issue 2-3, 2006, Pages 214-221

  Martucci, Livia ^a   Wong, Albert H C ^a   De Luca, Vincenzo ^a   Likhodi, Olga ^a   Wong, Gregory W H ^a   King, Nicole ^a   Kennedy, James L ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Bipolar disorder; Family based association test; Gene expression; NR2B subunit gene (GRIN2B); Polymorphisms; Schizophrenia

Indexed keywords

MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ADULT; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN TISSUE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA DETERMINATION; FEMALE; FREQUENCY ANALYSIS; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR FAMILY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PSYCHOSIS; SAMPLE; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; MALE; PEDIGREE; POLYMORPHISM, GENETIC; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 33646535427     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.02.001     Document Type: Article

References (52)

1. Akbarian S., Sucher N.J., et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16 1 (1996) 19-30
2. American Psychiatric Association A. Diagnostic and Statistical Manual of Mental Disorders. fourth edition (1994), American Psychiatric Association, Washington, DC
3. Aoki C., Bredt D.S., et al. The subcellular distribution of nitric oxide synthase relative to the NR1 subunit of NMDA receptors in the cerebral cortex. Prog. Brain Res. 118 (1998) 83-97
4. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry 7 4 (2002) 405-411
5. Benes F.M., Todtenkopf M.S., et al. GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus 11 5 (2001) 482-491
6. Chiu H.J., Wang Y.C., et al. Association analysis of the genetic variants of the N-methyl d-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese. Neuropsychobiology 47 4 (2003) 178-181
7. Cull-Candy S., Brickley S., et al. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11 3 (2001) 327-335
8. 2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists. Ann. Pharmacother. 33 4 (1999) 480-488
9. Gao X.M., Sakai K., et al. Ionotropic glutamate receptors and expression of N-methyl-d-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry 157 7 (2000) 1141-1149
10. Grimwood S., Slater P., et al. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. NeuroReport 10 3 (1999) 461-465
11. Hedges L.V., Olkin I., et al. Statistical Methods for Meta-Analysis (1985), Academic Press, London 39
12. Henson J., Saffer J., et al. The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann. Neurol. 32 1 (1992) 72-77
13. Hokin L.E., Dixon J.F., et al. A novel action of lithium: stimulation of glutamate release and inositol 1,4,5 trisphosphate accumulation via activation of the N-methyl d-aspartate receptor in monkey and mouse cerebral cortex slices. Adv. Enzyme Regul. 36 (1996) 229-244
14. Hong C.J., Yu Y.W., et al. Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia. Psychiatr. Genet. 11 4 (2001) 219-222
15. Ishii T., Moriyoshi K., et al. Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. J. Biol. Chem. 268 4 (1993) 2836-2843
16. Jan de Beur S.M., Ding C.L., et al. Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes. J. Clin. Endocrinol. Metab. 85 6 (2000) 2239-2246
17. Knable M.B., Barci B.M., et al. Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers. Mol. Psychiatry 7 4 (2002) 392-404
18. Krupp J.J., Vissel B., et al. Calcium-dependent inactivation of recombinant N-methyl-d-aspartate receptors is NR2 subunit specific. Mol. Pharmacol. 50 6 (1996) 1680-1688
19. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 19 (1991) 5444
20. Laird N.M., Horvath S., et al. Implementing a unified approach to family-based tests of association. Genet. Epidemiol. 19 Suppl 1 (2000) S36-S42
21. Laube B., Hirai H., et al. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 18 3 (1997) 493-503
22. Laurie D.J., Bartke I., et al. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res. Mol. Brain Res. 51 1-2 (1997) 23-32
23. Law A.J., and Deakin J.F. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. NeuroReport 12 13 (2001) 2971-2974
24. Lewis C.M., Levinson D.F., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder: Part II. Schizophrenia. Am. J. Hum. Genet. 73 1 (2003) 34-48
25. Lijam N., Paylor R., et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90 5 (1997) 895-905
26. Loftis J.M., and Janowsky A. The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol. Ther. 97 1 (2003) 55-85
27. Loscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog. Neurobiol. 58 1 (1999) 31-59
28. Macciardi F. Multiple testing in genetic association studies: to correct or not to correct?. Am. J. Med. Genet. 122B (2003) 31-32
29. Mandich P., Schito A.M., et al. Mapping of the human NMDAR2B receptor subunit gene (GRIN2B) to chromosome 12p12. Genomics 22 1 (1994) 216-218
30. Maxwell, M.E., 1992. Family Interview for Genetic Studies. from http://www.grb.nimh.nih.gov/interviews.html.
31. Miyatake R., Furukawa A., et al. Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia. Mol. Psychiatry 7 10 (2002) 1101-1106
32. Moon I.S., Apperson M.L., et al. The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-d-aspartate receptor subunit 2B. Proc. Natl. Acad. Sci. U. S. A. 91 9 (1994) 3954-3958
33. Mundo E., Tharmalingham S., et al. Evidence that the N-methyl-d-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol. Psychiatry 8 2 (2003) 241-245
34. Nishiguchi N., Shirakawa O., et al. Novel polymorphism in the gene region encoding the carboxyl-terminal intracellular domain of the NMDA receptor 2B subunit: analysis of association with schizophrenia. Am. J. Psychiatry 157 8 (2000) 1329-1331
35. Nonaka S., Hough C.J., et al. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-d-aspartate receptor-mediated calcium influx. Proc. Natl. Acad. Sci. U. S. A. 95 5 (1998) 2642-2647
36. Ohtsuki T., Sakurai K., et al. Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol. Psychiatry 6 2 (2001) 211-216
37. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52 12 (1995) 998-1007
38. Owen M.J. Molecular genetic studies of schizophrenia. Brain Res. Brain Res. Rev. 31 2-3 (2000) 179-186
39. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 316 7139 (1998) 1236-1238
40. Rabinowitz D., and Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum. Hered. 50 4 (2000) 211-223
41. Rosenberg N.A., Pritchard J.K., et al. Genetic structure of human populations. Science 298 5602 (2002) 2381-2385
42. Scarr E., Pavey G., et al. Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord. 5 4 (2003) 257-264
43. Schito A.M., Pizzuti A., et al. mRNA distribution in adult human brain of GRIN2B, a N-methyl-d-aspartate (NMDA) receptor subunit. Neurosci. Lett. 239 1 (1997) 49-53
44. Segurado R., Detera-Wadleigh S.D., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder: Part III. Bipolar disorder. Am. J. Hum. Genet. 73 1 (2003) 49-62
45. Smart T.G. Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation. Curr. Opin. Neurobiol. 7 3 (1997) 358-367
46. SMRI. http://www.stanleyresearch.org/programs/brain_collection.asp.
47. Tang Y.P., Shimizu E., et al. Genetic enhancement of learning and memory in mice. Nature 401 6748 (1999) 63-69
48. Torrey E.F., Webster M., et al. The Stanley Foundation Brain Collection and Neuropathology Consortium. Schizophr. Res. 44 2 (2000) 151-155
49. Tovar K.R., Sprouffske K., et al. Fast NMDA receptor-mediated synaptic currents in neurons from mice lacking the epsilon2 (NR2B) subunit. J. Neurophysiol. 83 1 (2000) 616-620
50. Tsuang M.T., Faraone S.V., et al. Identification of the phenotype in psychiatric genetics. Eur. Arch. Psychiatry Clin. Neurosci. 243 3-4 (1993) 131-142
51. Vicini S., Wang J.F., et al. Functional and pharmacological differences between recombinant N-methyl-d-aspartate receptors. J. Neurophysiol. 79 2 (1998) 555-566
52. Wong A.H., Likhodi O., et al. Genetics and transcription of 14-3-3 isoforms in schizophrenia and bipolar disorder. Schizophr. Res. (2005)